Research letterSirolimus for treatment of verrucous venous malformation: A retrospective cohort study
References (4)
- et al.
A somatic MAP3K3 mutation is associated with verrucous venous malformation
Am J Hum Genet
(2015) - et al.
Verrucous hemangioma: a clinicopathological and immunohistochemical analysis of 74 cases
J Cutan Pathol
(2014)
There are more references available in the full text version of this article.
Cited by (19)
Medical Management and Therapeutic Updates on Vascular Anomalies of the Head and Neck: Part 2
2024, Oral and Maxillofacial Surgery Clinics of North AmericaTopical rapamycin in superficial lymphatic malformation: Microcystic lymphatic malformation or verrucous venous malformation?
2023, Journal of the American Academy of DermatologyReply to “Comment on ‘Sirolimus for the treatment of verrucous venous malformation: A retrospective cohort study': Are we missing the lymphatic malformation component?”
2023, Journal of the American Academy of DermatologyComment on “Sirolimus for the treatment of verrucous venous malformation: A retrospective cohort study”: Are we missing the lymphatic malformation component?
2023, Journal of the American Academy of DermatologyVerrucous Venous Malformation and Overgrowth: About Two Cases
2022, Actas Dermo-SifiliograficasDiagnostic Value of Cutaneous Ultrasound in Verrucous Venous Malformation
2021, Actas Dermo-Sifiliograficas
Drs Chen and Zhen contributed equally to the first author.
Funding sources: None.
Conflicts of interest: None disclosed.
Reprints not available from the authors.
© 2018 by the American Academy of Dermatology, Inc.